Reports for LAMIVUDINE

Ingredient

LAMIVUDINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LAMIVUDINE 150MG TABLET Resolved 2017-03-11 2017-05-16 664
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 300MG 150MG TABLET Resolved 2017-03-10 2017-05-23 14
APO-LAMIVUDINE 300MG TABLET Resolved 2017-07-11 2017-08-31 15271
HEPTOVIR 5MG SOLUTION Resolved 2017-08-10 2017-09-13 18727
APO-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2018-01-03 2018-01-16 34878
APO-LAMIVUDINE-ZIDOVUDINE 300MG 150MG TABLET Resolved 2017-12-06 2018-07-03 31907
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2018-02-06 2018-08-24 38860
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2017-10-12 2018-10-03 25829
APO-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2019-01-03 2019-01-23 71098
MYLAN-ABACAVIR/LAMIVUDINE 600MG 300MG TABLET Resolved 2018-10-23 2019-02-16 65420

Showing 1 to 10 of 26

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
TRIZIVIR 300MG 300MG 150MG TABLET Discontinued 2019-09-18 2019-09-18 94278
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
TEVA-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Discontinued 2020-01-24 2020-01-24 104260
HEPTOVIR 5MG SOLUTION Discontinued 2022-05-13 2022-07-22 160503
HEPTOVIR 100MG TABLET Discontinued 2022-05-13 2022-08-10 160500

Showing 1 to 7 of 7